FDA designated an Endologix  warning over a catheter introducer as a Class I recall

Six months after publication of key studies, CombiMatrix sees growth in prenatal testing adoption

We are still working out some issues with the Twitter functionality for our social media monitoring section, but should have it resolved shortly.  We apologize for the incovenience.